• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

    4/22/24 7:07:00 AM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    • Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential
    • Enhancing Elekta's radiation therapy offerings with GE HealthCare's MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems
    • This new collaboration complements GE HealthCare and Elekta's existing global commercial collaboration agreement, which enables the two companies to provide hospitals and cancer patients a comprehensive radiation therapy offering across imaging and treatment

    Weeks after closing its acquisition of MIM Software – a global provider of medical imaging analysis and artificial intelligence (AI) solutions – GE HealthCare is proud to announce the expansion of its relationship with Elekta (EKTA-B.ST), a leader in precision radiation oncology. Together, the companies aim to accelerate innovation in software solutions that will help improve workflows, increase throughput, and enhance user experience for clinicians, while also enabling greater precision in treatment and less time spent at the hospital for patients.

    Nearly two-thirds of all cancer patients receive radiation therapy (RT), a type of treatment that can either be given alone or in combination with surgery and/or chemotherapy.i However, it can take weeks for a patient to go from a cancer diagnosis to treatment, in part due to a persistent lack of interoperability and automation – a delay that may have a significant impact on patient outcomes.ii Furthermore, therapy advancements – such as hypofractionation, adaptive therapy, and more – may require precise, multi-modality imaging supported by advanced post processing.

    "Our decision to join GE HealthCare was driven by a ‘shared vision of maximizing impact' and our motivation for this collaboration with Elekta is no different," explains Andy Nelson, CEO of MIM Software, GE HealthCare. "For decades, we have engaged directly with clinicians to understand their needs and bridge the divide by building solutions that streamline their clinical workflows and reduce treatment delays for patients. With the evolution of treatment planning software, we stand to make an impact on clinicians and patients worldwide. Now, we are excited to extend the reach of these efforts by boosting Elekta's offerings with our vendor-agnostic solutions."

    GE HealthCare's MIM Software portfolio with Elekta's treatment planning software offerings will enable advanced and innovative oncology treatment planning in the delivery of radiation therapy. The collaboration is expected to drive innovation within treatment planning, harnessing MIM Software and Elekta's respective strengths in regional markets to make solutions available globally.

    "While this is an exciting step for both companies it's a significant development for radiation therapy clinics and their patients," adds Maurits Wolleswinkel, Elekta's President Linac and Software Solutions. "This is a natural expansion of our portfolio, combining our innovative dose planning capabilities with MIM Software's proven track record of physician-preferred tools . Clinically, it means delivering on improved automation and adaptive therapy planning, as well as greater speed and accuracy. And our vendor-agnostic philosophy ensures that all radiation therapy providers stand to gain from this collaboration."

    Today's announcement complements GE HealthCare and Elekta's existing global collaboration agreement, which enables the two companies to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy.

    "GE HealthCare and MIM Software have a long history of collaborating with healthcare systems, research institutions, and our fellow medical software and technology providers to meet the most pressing needs of our customers and their patients," shares Ben Newton, General Manager, Oncology, GE HealthCare. "Today's announcement is another demonstration of how MIM Software solutions enables advanced visualization and treatment planning offerings. We expect many more examples of this to come."

    GE HealthCare unites cancer screening with precision image guided therapy through an ecosystem of devices and digital solutions powered by AI to create seamless coordination and advance the patient journey throughout the entire pathway from early detection to follow up and assessment. This portfolio of oncology solutions – including Intelligent RT (iRT), Maestro, Discovery RT, and more – in combination with the company's expertise and collaborations help drive optimization and transform personalized cancer care for improved outcomes.

    For more information on GE HealthCare and MIM Software's radiation therapy solutions, please visit GEHealthCare.com and MIMSoftware.com. GE HealthCare will also showcase MIM Software solutions at the following global conferences:

    • European Society for Radiotherapy and Oncology (ESTRO) in Glasgow, United Kingdom;
    • American Society of Clinical Oncology (ASCO) in Chicago, Illinois; and
    • Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Toronto, Canada.

    About GE HealthCare Technologies Inc.

    GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

    Follow us on LinkedIn, X (formerly Twitter), and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.

    _________________________________

    i ASTRO Legislative Priorities. Available at https://www.astro.org/uploadedFiles/Main_Site/Meetings_and_Events/2015_Advocacy_Day/Advocacy%20Day%20-%20iPad%20-%20(Linked).pdf. Accessed April 2023.

    ii Li E, Clarke J, Ashrafian H, Darzi A, Neves AL. The Impact of Electronic Health Record Interoperability on Safety and Quality of Care in High-Income Countries: Systematic Review. J Med Internet Res. 2022 Sep 15;24(9):e38144. doi: 10.2196/38144. PMID: 36107486; PMCID: PMC9523524. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523524/

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240422400181/en/

    Get the next $GEHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    9/9/2024$90.00Neutral
    JP Morgan
    8/6/2024$100.00Buy
    Stifel
    5/30/2024$87.00Neutral
    Goldman
    More analyst ratings

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • GE HealthCare upgraded by UBS with a new price target

      UBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $73.00

      5/5/25 8:34:55 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare upgraded by Goldman with a new price target

      Goldman upgraded GE HealthCare from Neutral to Buy and set a new price target of $100.00 from $85.00 previously

      3/11/25 7:35:30 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare upgraded by Jefferies with a new price target

      Jefferies upgraded GE HealthCare from Hold to Buy and set a new price target of $103.00 from $95.00 previously

      1/8/25 7:50:38 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    SEC Filings

    See more
    • SEC Form 10-Q filed by GE HealthCare Technologies Inc.

      10-Q - GE HealthCare Technologies Inc. (0001932393) (Filer)

      4/30/25 6:26:15 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

      4/30/25 6:25:29 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form DEFA14A filed by GE HealthCare Technologies Inc.

      DEFA14A - GE HealthCare Technologies Inc. (0001932393) (Filer)

      4/10/25 7:20:11 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      11/12/24 12:53:28 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      10/22/24 4:16:16 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      4/2/24 4:07:29 PM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AI Healthcare Boom Gains Speed as Regulators and Innovators Align

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS Intelligence which polled C-suite executives at healthcare companies generating at least $1 billion in annual revenue, 90% already see positive ROI from investments in generative AI (GenAI). Analysts are projecting that by 2035 the gross value added by AI to the healthcare industry will be $461 billion on top of a baseline $2.26 trillion. Behind the scenes, several new AI healthcare tech developments are taking place, with updates rec

      5/5/25 12:35:00 PM ET
      $GEHC
      $SDGR
      $TEM
      $TVGN
      Medical Electronics
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Computer Software: Programming Data Processing
    • ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

      The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes GE HealthCare (NASDAQ:GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatment and more precise radiation therapy. According to the World Health Organization (WHO), cancer conti

      5/2/25 9:00:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare reports first quarter 2025 financial results

      Revenue growth was 3% year-over-year; Organic revenue growth* was 4% Net income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.0% versus 14.7% Diluted earnings per share (EPS) were $1.23 versus $0.81 for the prior year; Adjusted EPS* was $1.01 versus $0.90 Cash flow from operating activities was $250 million versus $419 million for the prior year; Free cash flow* was $98 million versus $274 million Updates full-year 2025 guidance Board of Directors authorizes a $1 billion share repurchase program GE HealthCare (NASDAQ:GEHC) today reported financial results for the first quarter ended March 31, 2025. GE He

      4/30/25 6:20:00 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    See more
    • GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

      GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

      4/9/25 9:00:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

      Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta's radiation therapy offerings with GE HealthCare's MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta's existing global commercial collaboration agreement, which enables the two companies to provide hospitals and cancer patients a comprehensive radiation therapy offering across imaging and treatment Weeks after closing its acquisition of MIM Software – a global provider of medical imaging analy

      4/22/24 7:07:00 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

      4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/2/24 6:00:38 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Technology Officer Kass-Hout Taha covered exercise/tax liability with 8,547 shares, decreasing direct ownership by 13% to 56,280 units (SEC Form 4)

      4/A - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/7/25 4:11:06 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form 3 filed by new insider Bankes Jeannette

      3 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/1/25 4:06:35 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • Chief Accounting Officer Newcomb George A. covered exercise/tax liability with 342 shares and was granted 1,156 shares, increasing direct ownership by 12% to 7,705 units (SEC Form 4)

      4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      3/5/25 7:47:57 PM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Financials

    Live finance-specific insights

    See more
    • GE HealthCare reports first quarter 2025 financial results

      Revenue growth was 3% year-over-year; Organic revenue growth* was 4% Net income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.0% versus 14.7% Diluted earnings per share (EPS) were $1.23 versus $0.81 for the prior year; Adjusted EPS* was $1.01 versus $0.90 Cash flow from operating activities was $250 million versus $419 million for the prior year; Free cash flow* was $98 million versus $274 million Updates full-year 2025 guidance Board of Directors authorizes a $1 billion share repurchase program GE HealthCare (NASDAQ:GEHC) today reported financial results for the first quarter ended March 31, 2025. GE He

      4/30/25 6:20:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare to announce first quarter 2025 results on April 30, 2025

      GE HealthCare (NASDAQ:GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical techno

      4/17/25 4:01:00 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare announces cash dividend for first quarter of 2025

      The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 payable on May 15, 2025 to all shareholders of record as of April 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than

      3/27/25 11:34:00 AM ET
      $GEHC
      Medical Electronics
      Health Care